Elizabeth B. Claus, MD, PhD is Attending Neurosurgeon and Director of Stereotactic Radiosurgery within the Department of Neurosurgery at Brigham and Women’s Hospital in Boston as well as Professor and Director of Medical Research in the Yale University School of Public Health. She is a member of the board of advisors for the Central Brain Tumor Registry of the United States (CBTRUS) and a past board member for the Acoustic Neuroma Association (ANA). Dr. Claus' work is focused in cancer and genetic epidemiology with an emphasis on the development of risk models for breast and brain tumors. She is the overall PI of the Meningioma Consortium, the Meningioma Genome-Wide Association Study, and the Yale Acoustic Neuroma Study as well as a co-investigator of the GLIOGENE (Genes for Glioma) and International Glioma Case/Control (GICC) projects. In addition to her research activities, Dr. Claus is a board-certified neurosurgeon with fellowship training in neurosurgical oncology at Brigham and Women’s Hospital; her clinical focus is on the treatment of glioma, meningioma, and brain metastases. In partnership with national patient brain tumor organizations including the American Brain Tumor Association (ABTA), the National Brain Tumor Society (NBTS) and the ANA, Dr. Claus is working to develop cost- and time-efficient web- and smartphone- based recruitment strategies to be used in the study of brain tumors. She has developed such work in collaboration with the ANA and has received funding from the ABTA/NBTS to commence development of a web-based registry for patients with low grade glioma (The International Low Grade Glioma Registry) in an effort to advance research efforts for this group of patients.
Recent News:
1) A New Web-based Study of Low-Grade Gliomas: Neurosurgeon Dr. Elizabeth Claus discusses her International Low Grade Glioma Registry, a study of the evolution of the low-grade glioma genome and the cells driving resistance to treatment.
Education
Videos
